Therefore, this study aimed to investigate the distribution of BCR::ABL1 mRNA variants in the different clinical phases of CML and their effect on hematological parameters, clinical variables, and patient survival in Mexican population. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.